Presynaptic α2-GABAA Receptors in Primary Afferent Depolarization and Spinal Pain Control

Spinal dorsal horn GABAA receptors are found both postsynaptically on central neurons and presynaptically on axons and/or terminals of primary sensory neurons, where they mediate primary afferent depolarization (PAD) and presynaptic inhibition. Both phenomena have been studied extensively on a cellular level, but their role in sensory processing in vivo has remained elusive, due to inherent difficulties to selectively interfere with presynaptic receptors. Here, we address the contribution of a major subpopulation of GABAA receptors (those containing the α2 subunit) to spinal pain control in mice lacking α2-GABAA receptors specifically in primary nociceptors (sns-α2−/− mice). sns-α2−/− mice exhibited GABAA receptor currents and dorsal root potentials of normal amplitude in vitro, and normal response thresholds to thermal and mechanical stimulation in vivo, and developed normal inflammatory and neuropathic pain sensitization. However, the positive allosteric GABAA receptor modulator diazepam (DZP) had almost completely lost its potentiating effect on PAD and presynaptic inhibition in vitro and a major part of its spinal antihyperalgesic action against inflammatory hyperalgesia in vivo. Our results thus show that part of the antihyperalgesic action of spinally applied DZP occurs through facilitated activation of GABAA receptors residing on primary nociceptors.

[1]  B. Komisaruk,et al.  Nociceptive responses to altered GABAergic activity at the spinal cord. , 1986, Life sciences.

[2]  B. Sakmann,et al.  Mechanism of anion permeation through channels gated by glycine and gamma‐aminobutyric acid in mouse cultured spinal neurones. , 1987, The Journal of physiology.

[3]  P. Seeburg,et al.  Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology , 1989, Nature.

[4]  P. Malherbe,et al.  In situ hybridization histochemistry reveals a diversity of GABAA receptor subunit mRNAs in neurons of the rat spinal cord and dorsal root ganglia , 1991, Neuroscience.

[5]  A. Light,et al.  Synaptic interactions between GABA-immunoreactive profiles and the terminals of functionally defined myelinated nociceptors in the monkey and cat spinal cord , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[6]  P. Seeburg,et al.  A single histidine in GABAA receptors is essential for benzodiazepine agonist binding. , 1992, The Journal of biological chemistry.

[7]  A. Kavookjian,et al.  Ultrastructural morphology, synaptic relationships, and CGRP immunoreactivity of physiologically identified c‐fiber terminals in the monkey spinal cord , 1993, The Journal of comparative neurology.

[8]  J. Barker,et al.  Ontogeny of GABAA receptor subunit mRNAs in rat spinal cord and dorsal root ganglia , 1993, The Journal of comparative neurology.

[9]  Duchen,et al.  Differential expression of membrane currents in dissociated mouse primary sensory neurons , 1990, Neuroscience.

[10]  R. Docherty,et al.  Expression of tetrodotoxin-resistant sodium channels in capsaicin-sensitive dorsal root ganglion neurons of adult rats , 1995, Neuroscience Letters.

[11]  F. Alt,et al.  Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  F. Cerveró,et al.  Mechanisms of touch-evoked pain (allodynia): a new model , 1996, Pain.

[13]  S. Bohlhalter,et al.  Laminar compartmentalization of GABAA-receptor subtypes in the spinal cord: an immunohistochemical study , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[14]  W. Willis Dorsal root potentials and dorsal root reflexes: a double-edged sword , 1999, Experimental Brain Research.

[15]  T. Yaksh,et al.  Characterization of spinal amino acid release and touch-evoked allodynia produced by spinal glycine or GABAA receptor antagonist , 1999, Neuroscience.

[16]  A. Dickenson,et al.  Effects of midazolam in the spinal nerve ligation model of neuropathic pain in rats , 2000, Pain.

[17]  T. Rülicke,et al.  Molecular and neuronal substrate for the selective attenuation of anxiety. , 2000, Science.

[18]  L. Trussell,et al.  Presynaptic glycine receptors enhance transmitter release at a mammalian central synapse , 2001, Nature.

[19]  J. Fritschy,et al.  A new benzodiazepine pharmacology. , 2002, The Journal of pharmacology and experimental therapeutics.

[20]  W. Neuhuber,et al.  PGE2 selectively blocks inhibitory glycinergic neurotransmission onto rat superficial dorsal horn neurons , 2002, Nature Neuroscience.

[21]  G. G. Nagy,et al.  The expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in neurochemically defined axonal populations in the rat spinal cord with emphasis on the dorsal horn , 2003, The European journal of neuroscience.

[22]  J. P. Lund,et al.  GABAergic Control of Action Potential Propagation along Axonal Branches of Mammalian Sensory Neurons , 2003, The Journal of Neuroscience.

[23]  T. Weissman,et al.  Localization and function of ATP and GABAA receptors expressed by nociceptors and other postnatal sensory neurons in rat , 2003, The Journal of physiology.

[24]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[25]  B. Bean,et al.  Role of Tetrodotoxin-Resistant Na+ Current Slow Inactivation in Adaptation of Action Potential Firing in Small-Diameter Dorsal Root Ganglion Neurons , 2003, The Journal of Neuroscience.

[26]  Stefan Offermanns,et al.  Conditional gene deletion in primary nociceptive neurons of trigeminal ganglia and dorsal root ganglia , 2004, Genesis.

[27]  U. Rudolph,et al.  Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. , 2004, Annual review of pharmacology and toxicology.

[28]  D. Kullmann,et al.  Presynaptic, extrasynaptic and axonal GABAA receptors in the CNS: where and why? , 2005, Progress in biophysics and molecular biology.

[29]  S. Narumiya,et al.  Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype. , 2005, The Journal of clinical investigation.

[30]  J. Lopez-Garcia,et al.  Electrophysiological and pharmacological characterisation of ascending anterolateral axons in the in vitro mouse spinal cord , 2005, Journal of Neuroscience Methods.

[31]  S. Narumiya,et al.  Spinal prostaglandin E receptors of the EP2 subtype and the glycine receptor α3 subunit, which mediate central inflammatory hyperalgesia, do not contribute to pain after peripheral nerve injury or formalin injection , 2006, Pain.

[32]  C. Asante,et al.  The Cell and Molecular Basis of Mechanical, Cold, and Inflammatory Pain , 2008, Science.

[33]  Kay Brune,et al.  Reversal of pathological pain through specific spinal GABAA receptor subtypes , 2008, Nature.

[34]  H. Zeilhofer Loss of glycinergic and GABAergic inhibition in chronic pain--contributions of inflammation and microglia. , 2008, International immunopharmacology.

[35]  Werner Sieghart,et al.  International Union of Pharmacology. LXX. Subtypes of γ-Aminobutyric AcidA Receptors: Classification on the Basis of Subunit Composition, Pharmacology, and Function. Update , 2008, Pharmacological Reviews.

[36]  F. Alvarez-Leefmans Chloride Transporters in Presynaptic Inhibition, Pain and Neurogenic Inflammation , 2009 .

[37]  David J Anderson,et al.  Distinct subsets of unmyelinated primary sensory fibers mediate behavioral responses to noxious thermal and mechanical stimuli , 2009, Proceedings of the National Academy of Sciences.

[38]  B. Bettler,et al.  Conditional gene deletion reveals functional redundancy of GABAB receptors in peripheral nociceptors in vivo , 2009, Molecular pain.